Registration Open for Preclinical Drug Development Course
Registration is now open for the first ZH3D Academy course series on Preclinical Drug Development. The three-part course provides practical and regulatory insights into nonclinical drug development and first-in-human enabling studies. Registration deadline: 7 October 2026.
.png)
The ZH3D Academy is pleased to announce its first course series on Preclinical Drug Development.
This three-part course provides practical and regulatory insights into nonclinical drug development, with a focus on early stages and first-in-human enabling studies.
Course dates
- 15 October 2026 (on-site)
- 22 October 2026 (online)
- 29 October 2026 (on-site)
Course lead
Dr. med. vet. Lisa Fischer, ERT
Head ZH3D Academy and Nonclinical Expert
Main lecturer
Dr.med.vet. Lisa Fischer, ERT
Head ZH3D Academy and Nonclinical Expert
Guest lecturers
Bärbel Ulmer, PhD, InSphero, Director Business Development
Dr.med.vet. Otto Maissen, BLV, Leiter Fachbereich Tierversuche
Language: English
Participants: Limited to 25
Registration deadline: 7 October 2026